The aim of this study is to explore the underlying mechanism of caspase-1/IL1B activation in HCC and further determine whether CD44s modulates caspase-1/IL1B activation through the autophagic degradation of caspase-1. This evidence concerns the gene CASP1 and hepatocellular carcinoma.